PPIs vs. H2RAs for Preventing GI Bleeding in Critically Ill Patients

Learn More From Dr. Alan Barkun on the AJG Podcast

Dr. Alan Barkun from McGill in Montreal, Canada is the author of a new systematic review and meta-analysis on PPIs vs. H2-receptor antagonists for stress related mucosal bleeding prophylaxis in critically ill patients. In a conversation with Dr. Paul Moayyedi, Professor Barkun reviews the evidence on the efficacy of PPIs vs. H2RAs in recurrent GI bleeding, ICU stay, mortality, and nosocomial pneumonia. (23:06)

Read the Article

Download from iTunes

Listen to the Podcast